Page 2 - Read Online
P. 2
Topic: Advances in DNA
Damage & Repair and Cancer
Drug Resistance
Eddy S. Yang, MD, PhD, received his MD and PhD
from the University of Miami School of Medicine. He
joined the University of Alabama at Birmingham (UAB)
in 2010 and is currently Professor and Vice Chair of
Translational Sciences in the Department of Radiation
Oncology. He also holds joint appointments in the
departments of cell, developmental, and integrative
biology as well as pharmacology and toxicology at UAB.
Dr. Yang is the inaugural holder of the ROAR Southeast
Cancer Foundation Endowed Chair and Director of the
Eddy S. Yang UAB Nanostring Laboratory.
Hazelrig Salter Radiation Oncology
Center, 1700 6th Avenue South
Birmingham, AL, USA.
Dr. van Waardenburg obtained his Ph.D. in Medical
Oncology from the University of Groningen, the
Netherlands, in the group of Drs. Nanno Mulder and
Elisabeth de Vries. His first post-doctoral fellowship was
at The Netherlands Cancer Institute, with Dr. Jan Schellens
and collaborator Dr. Jaap Brouwer (University of Leiden,
the Netherlands). His second post-doctoral fellowship
was at St. Jude Children’s Hospital, Memphis, TN, in the
Robert C.A.M. van group of Dr. Mary-Ann Bjornsti. He subsequently joined
Waardenburg the University of Alabama at Birmingham (UAB) and is
currently an Associate Professor in the Department of
Department of Pharmacology and Pharmacology and Toxicology. He also is the Director of
Toxicology, University of Alabama at the UAB Graduate Biomedical Sciences, Pathobiology,
Birmingham, Birmingham, AL, USA. Pharmacology and Physiology (P3) theme.
